ClinicalTrials.gg
Not yet recruitingNCT07790367PMT-IDUpdated Aug 27, 2026

Protection Motivation Theory-Based Education for Infectious Disease Prevention in Primary Care

An interventional study of Protection Motivation Theory-Based Educational Program in Infectious Disease Prevention, sponsored by Yuzuncu Yil University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Yuzuncu Yil University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the effect of a Protection Motivation Theory-based educational intervention on infectious disease perception, risk awareness, and protective health behaviors among adults attending primary care services. Participants will be assigned to an intervention group or a control group. The intervention group will receive a face-to-face educational program based on Protection Motivation Theory, while the control group will continue to receive routine health services without an additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4 using validated self-report measures.

Read the detailed description

This study is a controlled quasi-experimental study with a pretest-posttest design. It will be conducted among adults attending a primary care center. The study is designed to evaluate whether an educational intervention based on Protection Motivation Theory can improve participants' perceptions of infectious diseases, awareness of infectious disease risks, and protective health behaviors.

Participants will be allocated to an intervention group and a control group. Before the intervention, participants in both groups will complete baseline assessments. Participants in the intervention group will then receive a face-to-face educational program based on Protection Motivation Theory. The educational content will address routes of infectious disease transmission, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. Participants in the control group will not receive the educational intervention during the study period and will continue to receive routine health services.

At Week 4, participants in both groups will complete the post-intervention assessments. Changes in infectious disease perception, risk awareness, and protective health behaviors will be evaluated by comparing pre-intervention and post-intervention measurements between and within the groups.

02

Conditions studied

  • Infectious Disease Prevention

Keywords

  • Protection Motivation Theory
  • Infectious Diseases
  • Risk Awareness
  • Protective Health Behaviors
  • Health Education
  • Primary Health Care
03

In context

Communicable Diseases

626 studies on the registry are indexed under Communicable Diseases; 128 are open to participants now.

This study's planned enrollment of 200 is above the median of 89 across 380 interventional studies indexed under Communicable Diseases.

Browse Communicable Diseases studies →

Lead sponsor

Yuzuncu Yil University is the lead sponsor of 78 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older.
  • Being registered with and receiving services from the family health center where the study is conducted.
  • Being able to communicate in Turkish.
  • Voluntarily agreeing to participate in the study.
  • Being able to complete the study questionnaires and participate in the educational intervention.

Exclusion criteria

Exclusion Criteria:

  • Having a condition that prevents effective communication or participation in the educational intervention.
  • Declining to participate or withdrawing consent at any stage of the study.
  • Failing to complete the required pre-intervention or post-intervention assessments.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Protection Motivation Theory-Based Education Group

    Participants in this arm will receive a face-to-face educational program based on Protection Motivation Theory. The program will address infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors.

    Behavioral: Protection Motivation Theory-Based Educational Program

  • No intervention
    Control Group

    Participants in this arm will not receive the Protection Motivation Theory-based educational intervention during the study period and will continue to receive routine health services. They will complete the same pretest and posttest assessments as the intervention group.

Interventions

  • BehavioralProtection Motivation Theory-Based Educational Program

    Participants in the intervention group will receive a face-to-face educational program based on Protection Motivation Theory. The program will cover infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. The intervention is designed to enhance threat appraisal and coping appraisal related to infectious disease prevention and to promote protective health behaviors.

06

What researchers measure

Primary outcomes

  1. Change in Communicable Diseases Risk Awareness and Protection

    Communicable disease risk awareness and protection will be assessed using the Communicable Diseases Risk Awareness and Protection Scale (CDRAPS). The scale consists of 36 items rated on a 5-point Likert scale, with total scores ranging from 36 to 180. Higher scores indicate higher levels of communicable disease risk awareness and protection. Change in total score from baseline to Week 4 will be evaluated.

    Time frame: Baseline and Week 4

  2. Change in Perception Toward Infectious Diseases

    Perception toward infectious diseases will be assessed using the Perception Scale for Infectious Diseases. The scale consists of 34 items rated on a 5-point Likert scale, with total scores ranging from 34 to 170. Higher scores indicate a more positive perception toward infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

    Time frame: Baseline and Week 4

  3. Change in Preventive Health Behaviors for Emerging Infectious Diseases

    Preventive health behaviors will be assessed using the Turkish version of the Emerging Infectious Diseases Preventive Health Behavior Scale (EID-PHB-T-30). The scale consists of 30 items rated on a 5-point Likert scale, with total scores ranging from 30 to 150. Higher scores indicate higher levels of preventive health behaviors against emerging infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

    Time frame: Baseline and Week 4

07

Study locations

1 site
08

References and documents

Publications

  • Rakhshani T, Nikeghbal S, Kashfi SM, Kamyab A, Harsini PA, Jeihooni AK. Effect of educational intervention based on protection motivation theory on preventive behaviors of respiratory infections among hospital staff. Front Public Health. 2024 Jan 5;11:1326760. doi: 10.3389/fpubh.2023.1326760. eCollection 2023. PubMed 38249399 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07790367
Lead sponsor
Yuzuncu Yil University
Responsible party
Muhammet Faruk Yigit (Assistant Professor, Yuzuncu Yil University) — Principal investigator
First posted
Aug 27, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Oct 5, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Aug 27, 2026

Study contacts

Muhammet Faruk Yiğit, PhD
Contact
muhammetfarukyigit@yyu.edu.tr
+90 542 424 76 29
Muhammet Faruk Yigit, PhD
principal investigator · Yuzuncu Yil University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion